X0206 3 2012-10-30 0 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001528924 Glynn Michael 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421 false true false false SVP Global Business Operations Stock Option (Right to Buy) 57.56 2022-10-04 Common Stock 40000 D The stock option granted the reporting person is an option to purchase 40,000 shares of the issuer's common stock ("Shares"). 25% of such Shares vest and become exercisable on 09/03/2013, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter. Michael J. Glynn 2012-11-09